Compugen (CGEN) News Today → Biden’s $374B Giveaway Into This Sector (From DTI) (Ad) Free CGEN Stock Alerts $1.88 -0.02 (-1.05%) (As of 04/18/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadline3 Biotech Stocks with Potential Gains - Watch or Buy?stocknews.com - April 15 at 5:00 PMCompugen Ltd. (NASDAQ:CGEN) Sees Significant Increase in Short Interestmarketbeat.com - April 14 at 11:34 PMCompugen (NASDAQ:CGEN) Stock Crosses Above Two Hundred Day Moving Average of $1.63americanbankingnews.com - April 13 at 2:40 AMCompugen reports progress on cancer therapy COM503investing.com - April 11 at 10:56 PMCompugen Publishes Paper in Cancer Immunology Research Demonstrating Therapeutic Potential of COM503prnewswire.com - April 10 at 7:00 AMCompugen to Participate in Two Upcoming Investor Conferencesfinance.yahoo.com - April 3 at 8:16 AMIs Compugen Ltd. (NASDAQ:CGEN) Trading At A 31% Discount?finance.yahoo.com - April 2 at 8:12 AMCompugen Ltd. (NASDAQ:CGEN) Short Interest Down 9.4% in Februarymarketbeat.com - March 19 at 2:01 PMTruist Financial Reaffirms Their Buy Rating on Compugen (CGEN)markets.businessinsider.com - March 16 at 12:21 AMCompugen Selected for two Oral Presentations at the Keystone Symposium on Cancer Immunotherapyfinance.yahoo.com - March 11 at 8:54 AMCompugen Ltd. (CGEN) Q4 2023 Earnings Call Transcriptseekingalpha.com - March 8 at 12:22 AMBuy Rating Justified by Compugen’s Positive Clinical Outlook and Financial Stabilitymarkets.businessinsider.com - March 8 at 12:22 AMCompugen Ltd. (NASDAQ:CGEN) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 7 at 2:21 PMCompugen Ltd.: Compugen Reports Fourth Quarter and Full Year 2023 Resultsfinanznachrichten.de - March 7 at 9:20 AMCompugen to Present Data Reflecting its Diversified Immuno-Oncology Pipeline at AACR 2024prnewswire.com - March 6 at 7:00 AMCGEN Stock Earnings: Compugen Misses EPS, Beats Revenue for Q4 2023msn.com - March 5 at 12:23 PMCompugen: Q4 Earnings Snapshotsfgate.com - March 5 at 7:23 AMCompugen Reports Fourth Quarter and Full Year 2023 Resultsprnewswire.com - March 5 at 7:00 AMEarnings Preview For Compugenbenzinga.com - March 4 at 4:04 PMCompugen (NASDAQ:CGEN) Stock Price Crosses Above Two Hundred Day Moving Average of $1.29marketbeat.com - February 27 at 2:39 AMCompugen to Present at the Leerink Partners Global Biopharma Conference 2024finance.yahoo.com - February 26 at 7:49 AMCompugen to Present at the Leerink Partners Global Biopharma Conference 2024prnewswire.com - February 26 at 7:00 AMCompugen Stock (NASDAQ:CGEN), Short Interest Reportbenzinga.com - February 22 at 5:24 PMCompugen Stock (NASDAQ:CGEN) Dividends: History, Yield and Datesbenzinga.com - February 22 at 12:24 PMCompugen (CGEN) is a Great Momentum Stock: Should You Buy?finance.yahoo.com - February 21 at 4:21 PMCompugen to Release Fourth Quarter and Full Year 2023 Results on Tuesday, March 5, 2024finance.yahoo.com - February 20 at 9:57 AMCompugen to Release Fourth Quarter and Full Year 2023 Results on Tuesday, March 5, 2024prnewswire.com - February 20 at 7:00 AMCGEN Mar 2024 7.500 callfinance.yahoo.com - February 16 at 7:42 PMCGEN Mar 2024 1.500 putfinance.yahoo.com - February 16 at 7:42 PMCompugen Ltd.: Compugen Announces Appointment of Michelle Mahler M.D. as Chief Medical Officerfinanznachrichten.de - February 15 at 1:05 PMCompugen Announces Appointment of Michelle Mahler M.D. as Chief Medical Officerfinance.yahoo.com - February 15 at 8:05 AMCompugen Announces Appointment of Michelle Mahler M.D. as Chief Medical Officerprnewswire.com - February 15 at 7:00 AMCompugen (NASDAQ:CGEN) Stock Passes Above Two Hundred Day Moving Average of $1.18marketbeat.com - February 9 at 3:26 AMCompugen Ltd. (NASDAQ:CGEN) Short Interest Down 24.5% in Januarymarketbeat.com - January 28 at 12:58 PMShort Interest in Compugen Ltd. (NASDAQ:CGEN) Rises By 45.2%marketbeat.com - January 13 at 5:50 PMCompugen Ltd.: Compugen Regains Compliance with Nasdaq Minimum Bid Price Requirementfinanznachrichten.de - January 8 at 7:38 PMCompugen (NASDAQ:CGEN) Lowered to "Sell" at StockNews.commarketbeat.com - January 5 at 10:13 PMTop 4 Biotech Stock Buys for 2024 Gainsstocknews.com - December 26 at 2:26 PMCompugen’s Strategic Partnership with Gilead Bolsters Financial Position and Promises Growthmarkets.businessinsider.com - December 22 at 8:05 AMCompugen's stock rockets on deal with Gilead for anti-tumor drugmorningstar.com - December 22 at 12:55 AMCompugen Stock (NASDAQ:CGEN), Analyst Ratings, Price Targets, Predictionsbenzinga.com - December 21 at 9:53 AMGilead (GILD), Compugen Collaborate for Immunotherapy Programmsn.com - December 20 at 1:00 PMCompugen (NASDAQ:CGEN) delivers shareholders impressive 144% return over 1 year, surging 158% in the last week alonefinance.yahoo.com - December 20 at 8:00 AMWhy Is Cancer Immunotherapy-Focused Compugen Stock Is Trading Higher Today?msn.com - December 19 at 3:30 PMCompugen (NASDAQ:CGEN) Price Target Raised to $4.00marketbeat.com - December 19 at 3:25 PMWhy Compugen Shares Are Trading Higher By Over 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Sessionbenzinga.com - December 19 at 2:01 PMStock Traders Purchase Large Volume of Call Options on Compugen (NASDAQ:CGEN)marketbeat.com - December 19 at 10:51 AMStrong Open For Biotech Following Exclusive Agreement Announcementmsn.com - December 19 at 10:30 AMWhy Is Compugen (CGEN) Stock Up 189% Today?msn.com - December 19 at 10:30 AMmarketbeat.com - December 19 at 10:19 AM Get Compugen News Delivered to You Automatically Sign up to receive the latest news and ratings for CGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address Biden’s $374B Giveaway Into This Sector (Ad)Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here Click here for the full story CGEN Media Mentions By Week CGEN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CGEN News Sentiment▼0.790.50▲Average Medical News Sentiment CGEN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CGEN Articles This Week▼31▲CGEN Articles Average Week Get Compugen News Delivered to You Automatically Sign up to receive the latest news and ratings for CGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Innate Pharma News X4 Pharmaceuticals News Agenus News INmune Bio News Genfit News Graphite Bio News Scilex News Elevation Oncology News Compass Therapeutics News Acumen Pharmaceuticals News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CGEN) was last updated on 4/18/2024 by MarketBeat.com Staff From Our PartnersSHOCKING Crypto Leak…Crypto 101 MediaBiden’s $374B Giveaway Into This SectorDTIBiden replacement revealed?Paradigm PressHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for 2024InvestorPlaceHow Biden has already won 2024Porter & CompanyTop 5 AI Stocks to Buy for 2024Market Moving TrendsIs AI Energy Really 4 Million Times More Powerful Than Oil? (Surprising Answer)Banyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Compugen Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.